In conclusion, we demonstrated the prevalence and clinicopathological characteristics of tumor PD‐L1 positivity in lung HGNET (i.e., SCLC and LCNEC) and the association of tumor PD‐L1 positivity with lower mortality in lung HGNET. This evidence concerns the gene CD274 and neoplasm.